Abstract

There are insufficient adequately powered clinical trials evaluating the incremental effect of the ABI, hsCRP level, or CAC score in risk assessment and initiation of preventive therapy. Furthermore, the clinical meaning of improvements in measures of calibration, discrimination, and reclassification risk prediction studies is uncertain.

Keywords

MedicineRisk assessmentDiseaseFramingham Risk ScorePhysical therapyAsymptomaticClinical trialMeta-analysisInternal medicine

Affiliated Institutions

Related Publications

Publication Info

Year
2018
Type
review
Volume
320
Issue
3
Pages
281-281
Citations
195
Access
Closed

External Links

Social Impact

Social media, news, blog, policy document mentions

Citation Metrics

195
OpenAlex

Cite This

Jennifer S Lin, Corinne V. Evans, Eric S. Johnson et al. (2018). Nontraditional Risk Factors in Cardiovascular Disease Risk Assessment. JAMA , 320 (3) , 281-281. https://doi.org/10.1001/jama.2018.4242

Identifiers

DOI
10.1001/jama.2018.4242